| Effect of dexamethasone in hospitalized patients with COVID-19–preliminary report P Horby, WS Lim, J Emberson, M Mafham, J Bell, L Linsell, N Staplin, ... MedRxiv, 2020.06. 22.20137273, 2020 | 11795* | 2020 |
| International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma KF Chung, SE Wenzel, JL Brozek, A Bush, M Castro, PJ Sterk, IM Adcock, ... European respiratory journal 43 (2), 343-373, 2014 | 4336 | 2014 |
| Cluster analysis and clinical asthma phenotypes P Haldar, ID Pavord, DE Shaw, MA Berry, M Thomas, CE Brightling, ... American journal of respiratory and critical care medicine 178 (3), 218-224, 2008 | 2424 | 2008 |
| A large-scale, consortium-based genomewide association study of asthma MF Moffatt, IG Gut, F Demenais, DP Strachan, E Bouzigon, S Heath, ... New England Journal of Medicine 363 (13), 1211-1221, 2010 | 2336 | 2010 |
| Asthma exacerbations and sputum eosinophil counts: a randomised controlled trial RH Green, CE Brightling, S McKenna, B Hargadon, D Parker, P Bradding, ... The Lancet 360 (9347), 1715-1721, 2002 | 2194 | 2002 |
| Mepolizumab and exacerbations of refractory eosinophilic asthma P Haldar, CE Brightling, B Hargadon, S Gupta, W Monteiro, A Sousa, ... New England journal of medicine 360 (10), 973-984, 2009 | 2159 | 2009 |
| Mast-cell infiltration of airway smooth muscle in asthma CE Brightling, P Bradding, FA Symon, ST Holgate, AJ Wardlaw, ID Pavord New England Journal of Medicine 346 (22), 1699-1705, 2002 | 1591 | 2002 |
| Diagnosis and management of cough executive summary: ACCP evidence-based clinical practice guidelines RS Irwin, MH Baumann, DC Bolser, LP Boulet, SS Braman, CE Brightling, ... Chest 129 (1), 1S-23S, 2006 | 1271 | 2006 |
| Acute exacerbations of chronic obstructive pulmonary disease: identification of biologic clusters and their biomarkers M Bafadhel, S McKenna, S Terry, V Mistry, C Reid, P Haldar, ... American journal of respiratory and critical care medicine 184 (6), 662-671, 2011 | 1249 | 2011 |
| Analysis of induced sputum in adults with asthma: identification of subgroup with isolated sputum neutrophilia and poor response to inhaled corticosteroids RH Green, CE Brightling, G Woltmann, D Parker, AJ Wardlaw, ID Pavord Thorax 57 (10), 875-879, 2002 | 1126 | 2002 |
| Evidence of a role of tumor necrosis factor α in refractory asthma MA Berry, B Hargadon, M Shelley, D Parker, DE Shaw, RH Green, ... New England Journal of Medicine 354 (7), 697-708, 2006 | 1077 | 2006 |
| Uniform definition of asthma severity, control, and exacerbations: document presented for the World Health Organization Consultation on Severe Asthma J Bousquet, E Mantzouranis, AA Cruz, N Aït-Khaled, CE Baena-Cagnani, ... Journal of Allergy and Clinical Immunology 126 (5), 926-938, 2010 | 1004 | 2010 |
| Global Initiative for Asthma Strategy 2021: executive summary and rationale for key changes HK Reddel, LB Bacharier, ED Bateman, CE Brightling, GG Brusselle, ... American journal of respiratory and critical care medicine 205 (1), 17-35, 2022 | 867 | 2022 |
| Allergic Rhinitis and its Impact on Asthma (ARIA): achievements in 10 years and future needs J Bousquet, HJ Schünemann, B Samolinski, P Demoly, ... Journal of Allergy and Clinical Immunology 130 (5), 1049-1062, 2012 | 821 | 2012 |
| British guideline on the management of asthma British Thoracic Society Scottish Intercollegiate Guidelines Network Thorax 63, iv1-iv121, 2008 | 784 | 2008 |
| Sputum eosinophilia and short-term response to prednisolone in chronic obstructive pulmonary disease: a randomised controlled trial CE Brightling, W Monteiro, R Ward, D Parker, MDL Morgan, AJ Wardlaw, ... The Lancet 356 (9240), 1480-1485, 2000 | 757 | 2000 |
| Non-eosinophilic cor ticosteroid unresponsive asthma ID Pavord, CE Brightling, G Woltmann, AJ Wardlaw The Lancet 353 (9171), 2213-2214, 1999 | 691 | 1999 |
| Blood eosinophils to direct corticosteroid treatment of exacerbations of chronic obstructive pulmonary disease: a randomized placebo-controlled trial M Bafadhel, S McKenna, S Terry, V Mistry, M Pancholi, P Venge, ... American journal of respiratory and critical care medicine 186 (1), 48-55, 2012 | 674 | 2012 |
| Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial RECOVERY Collaborative Group, PW Horby, M Mafham, L Peto, ... Medrxiv, 2021.06. 15.21258542, 2021 | 669* | 2021 |
| Medium-term effects of SARS-CoV-2 infection on multiple vital organs, exercise capacity, cognition, quality of life and mental health, post-hospital discharge B Raman, MP Cassar, EM Tunnicliffe, N Filippini, L Griffanti, ... EClinicalMedicine 31, 2021 | 666 | 2021 |
